Difference between revisions of "Team:Fudan-TSI/Parts"
| Line 1,829: | Line 1,829: | ||
</div> | </div> | ||
</div> | </div> | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
</div> | </div> | ||
</div> | </div> | ||
Revision as of 06:15, 18 October 2019
Parts Overview
This year Team Fudan-TSI presents you with a toolbox for our in vivo sequence-specific continuous mutagenesis system(R-Evolution). This toolbox includes promoters, RBSs, terminators, CDSs and other regulatory parts which undergo careful design and optimization. The Moloney Murine Leukemia Virus Reverse Transcriptase (MMLV RT), which is new to the registry, and Cre Recombinase are the most important components of our system for which we have put emphasis on the construction and characterization of these two parts. Also, our improved lac repressor protein is fully equipped for regulating protein expression.